Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) - the ...

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response (MPR) rates ...

Mount Sinai Medical Center proudly announces the appointment of Dr. Eric S. Weiss, MD, MPH, as President of Cardiovascular & Thoracic Surgery (CVTS) and joining Dr. Steve Xydas as Co-Director of Valve ...

Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...

Ankit Bharat, MD, can still remember Cornelia Tischmacher stopping their first telehealth conversation every few words to ...

RESULTS: The 4-year recurrence-free rate was 25% for the control arm and 46% for the chemotherapy group (P = .04).The 4-year liver recurrence-free rate was 43% in the control group and 67% in the ...

Background: Disease persistence or relapse following curative-intent surgery or radiotherapy of high-risk prostate cancer is not uncommon. This is attributable, in part, to a failure of accurate ...

Netherlands yDepartment of Otolaryngology and Head and Neck Surgery, St James's Hospital and The Royal Victoria Eye and Ear Hospital, Dublin, Ireland zFoundation IRCCS, Division of Medical Oncology, ...